These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
800 related items for PubMed ID: 19581765
1. [Change in the serologic markers of hepatitis B after allogenic hematopoietic stem-cell transplantation]. Woo SY, Cho SH, Lee SM, Koh MB, Noh CH, Kim CW, Choi JY, Yang JM, Han JY, Lee YS. Korean J Hepatol; 2009 Jun; 15(2):131-9. PubMed ID: 19581765 [Abstract] [Full Text] [Related]
2. Hepatitis B virus infection in allogeneic bone marrow transplantation. Ustün C, Koç H, Karayalcin S, Akyol G, Gürman G, Ilhan O, Akan H, Ozcan M, Arslan O, Konuk N, Uysal A, Beksaç M. Bone Marrow Transplant; 1997 Aug; 20(4):289-96. PubMed ID: 9285543 [Abstract] [Full Text] [Related]
3. Changes in serologic markers of hepatitis B following autologous hematopoietic stem cell transplantation. Uhm JE, Kim K, Lim TK, Park BB, Park S, Hong YS, Lee SC, Hwang IG, Koh KC, Lee MH, Ahn JS, Kim WS, Jung CW, Kang WK. Biol Blood Marrow Transplant; 2007 Apr; 13(4):463-8. PubMed ID: 17382252 [Abstract] [Full Text] [Related]
4. Hepatitis B virus reactivation and efficacy of prophylaxis with lamivudine in patients undergoing allogeneic stem cell transplantation. Giaccone L, Festuccia M, Marengo A, Resta I, Sorasio R, Pittaluga F, Fiore F, Boccadoro M, Rizzetto M, Bruno B, Marzano A. Biol Blood Marrow Transplant; 2010 Jun; 16(6):809-17. PubMed ID: 20060484 [Abstract] [Full Text] [Related]
5. Maintenance of immune memory to the hepatitis B envelope protein following adoptive transfer of immunity in bone marrow transplant recipients. Ilan Y, Nagler A, Zeira E, Adler R, Slavin S, Shouval D. Bone Marrow Transplant; 2000 Sep; 26(6):633-8. PubMed ID: 11035369 [Abstract] [Full Text] [Related]
6. Long-term surveillance of haematopoietic stem cell recipients with resolved hepatitis B: high risk of viral reactivation even in a recipient with a vaccinated donor. Knöll A, Boehm S, Hahn J, Holler E, Jilg W. J Viral Hepat; 2007 Jul; 14(7):478-83. PubMed ID: 17576389 [Abstract] [Full Text] [Related]
7. Heart transplantation using donors positive for hepatitis. Wang SS, Chou NK, Ko WJ, Yu HY, Chen YS, Hsu RB, Huang SC, Chi NH, Tsao CI, Lai MY, Liau CS, Lee YT. Transplant Proc; 2004 Oct; 36(8):2371-3. PubMed ID: 15561252 [Abstract] [Full Text] [Related]
8. Reactivation of resolved hepatitis B virus infection after allogeneic haematopoietic stem cell transplantation. Knöll A, Boehm S, Hahn J, Holler E, Jilg W. Bone Marrow Transplant; 2004 May; 33(9):925-9. PubMed ID: 15004543 [Abstract] [Full Text] [Related]
9. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection. Su WJ, Ho MC, Ni YH, Chen HL, Hu RH, Wu YM, Chang MH, Lee PH. J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883 [Abstract] [Full Text] [Related]
10. De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population. Prieto M, Gómez MD, Berenguer M, Córdoba J, Rayón JM, Pastor M, García-Herola A, Nicolás D, Carrasco D, Orbis JF, Mir J, Berenguer J. Liver Transpl; 2001 Jan; 7(1):51-8. PubMed ID: 11150423 [Abstract] [Full Text] [Related]
11. [Hepatitis B virus reactivation in patients with HBs antibodies after allogeneic hematopoietic stem cell transplantation]. Fujimaki K, Nakaseko C, Oshima K, Sakai M, Chou R, Kanda Y, Nishimura M, Kanamori H, Sakamaki H. Rinsho Ketsueki; 2007 May; 48(5):386-90. PubMed ID: 17571583 [Abstract] [Full Text] [Related]
12. Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy. Sheng WH, Kao JH, Chen PJ, Huang LM, Chang SY, Sun HY, Hung CC, Chen MY, Chang SC. Clin Infect Dis; 2007 Nov 01; 45(9):1221-9. PubMed ID: 17918088 [Abstract] [Full Text] [Related]
13. Changes of hepatitis B virus serologic status after allogeneic hematopoietic stem cell transplantation and impact of donor immunity on hepatitis B virus. Park S, Kim K, Kim DH, Jang JH, Kim SJ, Kim WS, Jung CW, Koh KC. Biol Blood Marrow Transplant; 2011 Nov 01; 17(11):1630-7. PubMed ID: 21565276 [Abstract] [Full Text] [Related]
14. Hepatitis B virus infection after renal transplantation in the presence of antibody to hepatitis B surface antigen immunity. Kim KH, Ahn SH, Chung HY, Paik YH, Lee KS, Kim YS, Chon CY, Moon YM, Han KH. J Gastroenterol Hepatol; 2004 Aug 01; 19(8):847-53. PubMed ID: 15242485 [Abstract] [Full Text] [Related]
15. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice. Bhatti FA, Ullah Z, Salamat N, Ayub M, Ghani E. Transfusion; 2007 Jan 01; 47(1):74-9. PubMed ID: 17207233 [Abstract] [Full Text] [Related]
18. Clearance of hepatitis B surface antigen after bone marrow transplantation: role of adoptive immunity transfer. Lau GK, Lok AS, Liang RH, Lai CL, Chiu EK, Lau YL, Lam SK. Hepatology; 1997 Jun 01; 25(6):1497-501. PubMed ID: 9185774 [Abstract] [Full Text] [Related]